Pregnancy Outcomes: Effects of Metformin Study (POEM Study)

NCT02947503 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Gestational Diabetes
Insulin Resistance

Interventions

DRUG: Metformin TEVA 850 mg

Sponsor

Bethesda Diabetes Research Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]